Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration
International Journal of Nanomedicine · 2025-05 · Volume 20 · 6489-6514
DOI: 10.2147/ijn.s518486 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-05. Verfasst von Maryana Salamah und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Amides, Pyrazines, Liposomes, Antiviral Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
The present study aimed to develop and compare the intranasal applicability of favipiravir-loaded aspasomes (FAV-ASPs) using film hydration method, and favipiravir-loaded niosomes (FAV-NIOs) using ethanol injection method.
Methods
The FAV-ASP and FAV-NIO formulations were characterized according to nanoparticulate characteristics (DLS, drug loading, drug encapsulation efficacy, droplet size distribution), drug release and permeability behavior.
Results
The optimized FAV-ASP formulation (FAV-ASP8) consisted of FAV, ascorbyl palmitate, Span® 60 and cholesterol (30:25:25:50 w/w) with nano-scale size range (292.06 ± 2.10 nm), narrow polydispersity index (PDI) value (0.36 ± 0.03), adequate zeta potential (-74.73 ± 3.28 mV) and acceptable encapsulation efficiency (55.33 ± 0.41%). The optimized FAV-NIO formulation (FAV-NIO9) contained FAV, Span® 60 and cholesterol (30:30:40 w/w) with nano-scale size range (167.13 ± 1.60 nm), narrow PDI value (0.07 ± 0.01), adequate zeta potential (-27.1 ± 1.24 mV) and acceptable encapsulation efficiency (51.30 ± 0.69%). FAV-ASP8 and FAV-NIO9 were suitable for spraying into the nasal cavity (droplet size distribution
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.
- Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.
- Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., Budapest, Hungary.
- Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
- Faculty of Science and Informatics, Department of Applied & Environmental Chemistry, University of Szeged, Szeged, Hungary.
- Department of Oto-Rhino-Laryngology and Head-Neck Surgery, University of Szeged, Szeged, Hungary.
ORCID-Profile: Maryana Salamah, Balázs Volk, István Lekli, Gábor Kozma, Zoltán Kónya, Ágnes Szalenkó-Tőkés, Ágnes Kiricsi, László Rovó, Diána Balogh-Weiser, István Zupkó, Ildikó Csóka, Gábor Katona, György Tibor Balogh
Zitieren
APA
Salamah, M., Volk, B., Lekli, I., Bak, I., Gyöngyösi, A., Kozma, G., Kónya, Z., Szalenkó-Tőkés, Á., Kiricsi, Á., Rovó, L., Balogh-Weiser, D., Zupkó, I., Csóka, I., Katona, G., & Balogh, G. T. (2025). Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration. International Journal of Nanomedicine, Volume 20, 6489-6514. https://doi.org/10.2147/ijn.s518486
Vancouver
Salamah M, Volk B, Lekli I, Bak I, Gyöngyösi A, Kozma G, et al. Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration. International Journal of Nanomedicine. 2025;Volume 20:6489-6514. doi:10.2147/ijn.s518486
BibTeX
@article{Salamah2025,
author = {Salamah, Maryana and Volk, Balázs and Lekli, István and Bak, István and Gyöngyösi, Alexandra and Kozma, Gábor and Kónya, Zoltán and Szalenkó-Tőkés, Ágnes and Kiricsi, Ágnes and Rovó, László and Balogh-Weiser, Diána and Zupkó, István and Csóka, Ildikó and Katona, Gábor and Balogh, György Tibor},
title = {Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {6489--6514},
doi = {10.2147/ijn.s518486}
}
EUVIMED